Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin

The New England Journal of Medicine
C R SmithP S Lietman

Abstract

Two hundred fifty-eight patients with suspected sepsis were treated with tobramycin or gentamicin in a prospective, randomized, double-blind trial. One hundred forty-six patients received nine or more doses, had serial determinations of serum creatinine, and were evaluated for nephrotoxicity; 91 were able to cooperate with audiometry and were evaluated for auditory toxicity. Auditory toxicity developed in five of 47 (10 per cent) given gentamicin and five of 44 (11 per cent) given tobramycin. Nephrotoxicity developed in 19 of 72 (26 per cent) given gentamicin and nine of 74 (12 per cent) given tobramycin (P less than 0.025). The severity of the nephrotoxicity was not different; the mean increase in creatinine was 1.3 mg per 100 ml (114.9 mumol per liter) in both groups. Both the tobramycin and gentamicin groups had a similar mean age, initial serum creatinine level, total dose, serum aminoglycoside level, and duration of therapy. We conclude that tobramycin causes nephrotoxicity less frequently than does gentamicin.

References

May 1, 1978·The Journal of Antimicrobial Chemotherapy·M Akiyoshi
Feb 17, 1977·The New England Journal of Medicine·C R SmithP S Lietman
Jun 1, 1979·Antimicrobial Agents and Chemotherapy·C R SmithP S Lietman
Jan 1, 1978·Antimicrobial Agents and Chemotherapy·D N GilbertG Porter
May 1, 1978·The Journal of Antimicrobial Chemotherapy·W E FeeG R Lathrop
May 1, 1978·The Journal of Antimicrobial Chemotherapy·G KahlmeterC Kamme
May 1, 1978·The Journal of Antimicrobial Chemotherapy·M BarzaT Murray
May 1, 1978·The Journal of Antimicrobial Chemotherapy·R E BrummettD L Himes
Aug 1, 1976·The Journal of Infectious Diseases·P O MadsenA Mosegaard
Mar 16, 1972·The New England Journal of Medicine·D H SmithA L Smith
Feb 1, 1974·Antimicrobial Agents and Chemotherapy·J KlasterskyD Daneau
May 1, 1972·Annals of Internal Medicine·R A ChanP D Hoeprich
Feb 13, 1969·The New England Journal of Medicine·R H Gifford, A R Feinstein

❮ Previous
Next ❯

Citations

Jul 1, 1993·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·J H JoshiS C Schimpff
Mar 1, 1992·Indian Pediatrics·G R SinghR K Puri
Aug 1, 1995·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·N GordjaniM Brandis
Apr 12, 1995·Molecular and Cellular Biochemistry·P SandhyaP Varalakshmi
Jan 1, 1988·International Urology and Nephrology·L LöcseyG Kakuk
Jan 1, 1986·Indian Journal of Pediatrics·D A MacKintosh
Sep 1, 1981·Indian Journal of Pediatrics·A Kumar
Nov 14, 2008·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Detlef BockenhauerRobert Kleta
Mar 15, 2006·Digestive Diseases and Sciences·Zvi AckermanOrit Pappo
Mar 27, 1984·Clinica Chimica Acta; International Journal of Clinical Chemistry·T B VreeB Jongman-Nix
Jun 15, 1995·Clinica Chimica Acta; International Journal of Clinical Chemistry·M WernerR Nayar
Feb 1, 1995·Journal of Hepatology·M I LucenaF Sanchez de la Cuesta
Mar 1, 1989·Toxicology Letters·G D NuytsM E De Broe
Mar 1, 1989·Toxicology Letters·P M Tulkens
Aug 1, 1990·Toxicology Letters·P J GovaertsM E De Broe
Mar 1, 1995·Journal of Critical Care·R Hock, R J Anderson
Sep 5, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Brian G KeevilDonald P Cooper
Oct 7, 1993·The New England Journal of Medicine·J B Nadol
Oct 13, 2009·QJM : Monthly Journal of the Association of Physicians·Nicholas M SelbyNitin V Kolhe
Apr 11, 2008·Critical Care Medicine·Neesh Pannu, Mitra K Nadim
Apr 11, 2007·Current Opinion in Nephrology and Hypertension·Sushrut S WaikarGlenn M Chertow
Jun 1, 1995·British Journal of Clinical Pharmacology·E J BeggS B Duffull
Feb 1, 1994·Clinical and Experimental Pharmacology & Physiology·H O GarlandE S Harpur
Dec 1, 1981·Antimicrobial Agents and Chemotherapy·D J EdwardsJ J Schentag
Mar 1, 1982·Antimicrobial Agents and Chemotherapy·D E ZaskeR G Strate
Apr 1, 1982·Antimicrobial Agents and Chemotherapy·A E BrownD Armstrong
May 1, 1982·Antimicrobial Agents and Chemotherapy·J J SchentagM E Plaut
Nov 1, 1982·Antimicrobial Agents and Chemotherapy·M AdelmanJ J Schentag
Jan 1, 1983·Antimicrobial Agents and Chemotherapy·C R Smith, P S Lietman
Jan 1, 1983·Antimicrobial Agents and Chemotherapy·B F Farber, R C Moellering
Oct 1, 1983·Antimicrobial Agents and Chemotherapy·R G PennD K Giger
Oct 1, 1983·Antimicrobial Agents and Chemotherapy·G LaurentP M Tulkens
Nov 1, 1984·Antimicrobial Agents and Chemotherapy·J M GatellM T Jimenez de Anta
Feb 1, 1985·Antimicrobial Agents and Chemotherapy·R F AmbinderP S Lietman
Apr 1, 1985·Antimicrobial Agents and Chemotherapy·A ContrepoisC Carbon
Oct 1, 1985·Antimicrobial Agents and Chemotherapy·S T Donta, L A Lembke
Apr 1, 1987·Antimicrobial Agents and Chemotherapy·S S PedersenP Osterhammel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.